Table 3.
Prescription treatments reported by postmenopausal women seeking gynecologic care in the past 3 months
| Products | Total N = 114 |
|---|---|
| Estrogens | 25 (21.9) |
| Estrogen Type | |
| Premarin | 6 (5.3) |
| Estrace | 14 (12.3) |
| Vagifem | 3 (3.2) |
| Estring | 1 (0.9) |
| Femring | 1 (0.9) |
|
| |
| Antifungals | 9 (7.9) |
| Antifungal Type | |
| Miconazole | 6 (5.3) |
| Terazol | 1 (0.9) |
| Boric acid suppositories | 2 (1.8) |
|
| |
| Bacterial Vaginosis | |
| Metronidazole | 1 (0.9) |
|
| |
| Topical Steroids | 11 (9.6) |
| Topical Steroid Type | |
| Hydrocortizone1 | 7 (6.1) |
| Triamcinolone2 | 2 (1.8) |
| Clobetasol 3 | 2 (1.8) |
a
All values listed as n(%)
No women used terazol suppositories, nystatin ointment, nystatin powder, clindamycin vaginal preparations, topical gabapentin, topical amitriptyline, or Mycology II® (nystatin and triamcinolone) ointment